Merit Medical Systems (MMSI) Receives Daily Media Sentiment Rating of 0.21
News coverage about Merit Medical Systems (NASDAQ:MMSI) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Merit Medical Systems earned a daily sentiment score of 0.21 on Accern’s scale. Accern also assigned news stories about the medical instruments supplier an impact score of 45.505016113949 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the media headlines that may have impacted Accern Sentiment’s scoring:
- Raymond James Downgrades Rating On Merit Medical Systems, Inc. (MMSI) (highlightpress.com)
- Merit Medical to Participate at Five Conferences (feeds.benzinga.com)
- Raymond James Downgrades Merit Medical Systems, Inc. (MMSI) to Outperform (streetinsider.com)
- Merit Medical Systems, Inc. (MMSI) Cut to Outperform at UBS AG (americanbankingnews.com)
- Merit Medical Systems, Inc. (MMSI) Rating Lowered to Outperform at Citigroup Inc. (americanbankingnews.com)
Several equities analysts have recently commented on the stock. Raymond James Financial, Inc. restated an “outperform” rating and set a $44.00 price target on shares of Merit Medical Systems in a report on Monday. UBS AG cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a report on Monday. Piper Jaffray Companies restated a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a report on Friday, July 28th. Bank of America Corporation assumed coverage on shares of Merit Medical Systems in a report on Thursday, July 20th. They set a “buy” rating and a $44.00 price target on the stock. Finally, Citigroup Inc. cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price target on the stock. in a report on Monday. They noted that the move was a valuation call. One equities research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $40.52.
Shares of Merit Medical Systems (MMSI) opened at 40.20 on Wednesday. Merit Medical Systems has a 1-year low of $20.70 and a 1-year high of $42.60. The firm has a market cap of $2.02 billion, a price-to-earnings ratio of 57.26 and a beta of 1.26. The company has a 50 day moving average of $39.88 and a 200 day moving average of $34.08.
Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.29 by $0.07. The firm had revenue of $186.50 million for the quarter, compared to the consensus estimate of $181.46 million. Merit Medical Systems had a return on equity of 9.78% and a net margin of 4.87%. The company’s quarterly revenue was up 23.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.26 EPS. On average, equities analysts forecast that Merit Medical Systems will post $1.26 earnings per share for the current fiscal year.
In related news, Director A Scott Anderson sold 25,000 shares of the business’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $41.15, for a total value of $1,028,750.00. Following the sale, the director now owns 10,400 shares in the company, valued at approximately $427,960. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Richard W. Edelman sold 29,000 shares of the business’s stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $41.19, for a total value of $1,194,510.00. Following the completion of the sale, the insider now owns 35,000 shares in the company, valued at approximately $1,441,650. The disclosure for this sale can be found here. Insiders sold a total of 98,250 shares of company stock worth $3,932,799 in the last quarter. Company insiders own 5.00% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/08/30/merit-medical-systems-mmsi-receives-daily-media-sentiment-rating-of-0-21.html.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.